News From the Field
Tumor Cells in Blood May Signal Worse Prognosis in Head and Neck Cancer Patients
December 21, 2010
A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck might predict disease recurrence and reduced survival. An increased number of circulating tumor cells (CTCs) also correlates with a worse outcome. The findings of the on-going, prospective study suggest that CTCs might be a prognostic marker to help further individualize therapy. Currently, no prognostic blood test exists for this malignancy.
Ohio State University Medical Center
The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2014, its budget is $7.2 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives about 50,000 competitive requests for funding, and makes about 11,500 new funding awards. NSF also awards about $593 million in professional and service contracts yearly.
Get News Updates by Email
Useful NSF Web Sites:
NSF Home Page: http://www.nsf.gov
NSF News: http://www.nsf.gov/news/
For the News Media: http://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: http://www.nsf.gov/statistics/
Awards Searches: http://www.nsf.gov/awardsearch/